Citation: W. Nurnberg et al., AN EVALUATION OF SELECTED TOPICAL THERAPE UTIC AGENTS WITH CONSIDERATION OF THEIR APPLICATIONS, Hautarzt, 49(4), 1998, pp. 263-269
Authors:
SCHMIDTWEBER CB
RITTIG M
HAUSER I
NURNBERG E
EMMRICH F
PALOMBOKINNE E
KINNE RW
Citation: Cb. Schmidtweber et al., APOPTOTIC CELL-DEATH IN ACTIVATED MONOCYTES FOLLOWING INCORPORATION OF CLODRONATE-LIPOSOMES - REPLY, Journal of leukocyte biology, 61(5), 1997, pp. 644-645
Citation: R. Jachowicz et E. Nurnberg, ENHANCED RELEASE OF OXAZEPAM FROM TABLETS CONTAINING SOLID DISPERSIONS, International journal of pharmaceutics, 159(2), 1997, pp. 149-158
Citation: G. Beck et E. Nurnberg, CONSISTENCY TESTING OF TOPICALLY APPLIED SYSTEMS BY PENETRATION MEASUREMENTS, Die Pharmazie, 51(5), 1996, pp. 297-303
Authors:
NURNBERG B
HOPPE R
RUMENAPP U
HARHAMMER R
NURNBERG E
Citation: B. Nurnberg et al., A NONIONIC VESICLE LIPID ENHANCES MASTOPARAN-STIMULATED GTPASE ACTIVITY OF HETEROTRIMERIC G-PROTEINS, Pharmaceutical research, 12(3), 1995, pp. 366-369
Authors:
KINNE RW
SCHMIDTWEBER CB
HOPPE R
BUCHNER E
PALOMBOKINNE E
NURNBERG E
EMMRICH F
Citation: Rw. Kinne et al., LONG-TERM AMELIORATION OF RAT ADJUVANT ARTHRITIS FOLLOWING SYSTEMIC ELIMINATION OF MACROPHAGES BY CLODRONATE-CONTAINING LIPOSOMES, Arthritis and rheumatism, 38(12), 1995, pp. 1777-1790
Citation: W. Friess et E. Nurnberg, HEMOLYTIC-ACTIVITY OF TENSIDES - DETERMIN ATION OF THE INTERACTION BETWEEN O W-SURFACTANTS AND W/O-SURFACTANTS/, Die Pharmazie, 49(2-3), 1994, pp. 197-201